Scarica l'app Stockscreener
40.18
11.67%
4.20
Dopo l'orario di chiusura:
40.88
0.70
+1.74%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Nektar Therapeutics Borsa (NKTR) Ultime notizie
Nektar Therapeutics stock trend forecast2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Can Nektar Therapeutics recover in the next quarterQuarterly Trade Report & Expert Verified Stock Movement Alerts - Newser
Why Nektar Therapeutics Rippled Higher This Week - MSN
Nektar Therapeutics (NKTR) Surges on Rival's Disappointing Results - GuruFocus
Top chart patterns to watch in Nektar TherapeuticsJuly 2025 Drop Watch & Daily Market Momentum Tracking - Newser
Combining machine learning predictions for Nektar TherapeuticsMarket Sentiment Report & Weekly Setup with High ROI Potential - Newser
What does recent volatility data suggest for Nektar TherapeuticsJuly 2025 Summary & Real-Time Volume Triggers - Newser
Nektar Therapeutics (NKTR) Surges 26.02% as Sanofi's Underwhelming AD Trial Highlights Competitive Edge - AInvest
Candlestick signals on Nektar Therapeutics stock todayPrice Action & Precise Entry and Exit Recommendations - Newser
Insider Sell: Jonathan Zalevsky Sells Shares of Nektar Therapeutics (NKTR) - GuruFocus
Long term hold vs stop loss in Nektar Therapeutics2025 Trading Volume Trends & Real-Time Volume Surge Alerts - Newser
Can Nektar Therapeutics expand into new marketsEarnings Risk Summary & Reliable Volume Spike Alerts - خودرو بانک
Analysts postive on Nektar opportunity after Sanofi data - Investing.com
What's Going On With Nektar Therapeutics Stock On Thursday? - Benzinga
Nektar Therapeutics Surges 19.5%: What's Fueling the Sharp Intraday Move? - AInvest
Nektar Therapeutics Soars 23.4% on FDA Fast Track Designation and Analyst Upgrades—Can This Momentum Sustain? - AInvest
Nektar Therapeutics to Participate in Two Investor Conferences in September - Eastern Progress
Nektar Therapeutics Shares Rise Amid Sanofi's Disappointing Eczema Drug Results - AInvest
Nektar Therapeutics Shares Jump as Sanofi's Eczema Drug Results Miss Expectations in Study - MarketScreener
Nektar Therapeutics Shares Soar After Sanofi’s Amlitelimab Falls Short - MSN
Nektar Therapeutics stock jumps after Sanofi’s amlitelimab data disappoints - Investing.com
Nektar Therapeutics Soars 14.05% on FDA Fast Track Designation - AInvest
Multi asset correlation models including Nektar Therapeutics2025 Support & Resistance & Daily Profit Maximizing Trade Tips - Newser
Using Ichimoku Cloud for Nektar Therapeutics technicalsWeekly Trade Report & Detailed Earnings Play Strategies - Newser
Published on: 2025-09-03 23:43:22 - Newser
Nektar Therapeutics’ Strategic Investor Engagement and Pipeline Progress - AInvest
Biotech Leader Nektar Therapeutics Set for Double Investor Conference Appearances in September 2025 - Stock Titan
Osteoarthritis Pipeline Analysis, 2025 by DelveInsight | ImmunityBio, Five Prime Therapeutics, Innate Pharma, Nektar Therapeutics, Cantargia, CureTech, Dynavax, Cellid Company, Kiadis Pharma, Multimmu - Barchart.com
Will Nektar Therapeutics outperform the market in YEARMarket Volume Report & Low Risk High Reward Trade Ideas - خودرو بانک
Published on: 2025-09-03 09:08:30 - Newser
Trend analysis for Nektar Therapeutics this weekFed Meeting & Comprehensive Market Scan Reports - Newser
Using fundamentals and technicals on Nektar Therapeutics2025 Volatility Report & Community Shared Stock Ideas - Newser
Nektar Therapeutics stock trend outlook and recovery path2025 AllTime Highs & Reliable Trade Execution Plans - Newser
Will Nektar Therapeutics announce a stock splitQuarterly Risk Review & Reliable Intraday Trade Plans - خودرو بانک
How to manage a losing position in Nektar TherapeuticsQuarterly Trade Report & Low Volatility Stock Recommendations - Newser
Should you wait for a breakout in Nektar TherapeuticsWeekly Profit Recap & Free Safe Entry Trade Signal Reports - Newser
Real time alert setup for Nektar Therapeutics performance2025 Major Catalysts & Growth Focused Entry Reports - Newser
Comparing Nektar Therapeutics in custom built stock radarsWeekly Market Summary & Momentum Based Trading Ideas - Newser
Nektar Therapeutics stock outlook for YEARJuly 2025 PreEarnings & Fast Entry High Yield Tips - Newser
Is Nektar Therapeutics stock ready for a breakout2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser
How to monitor Nektar Therapeutics with trend dashboardsMarket Volume Summary & Fast Exit and Entry Strategy Plans - Newser
Automated trading signals detected on Nektar TherapeuticsPortfolio Value Summary & Daily Stock Trend Watchlist - Newser
Will Nektar Therapeutics benefit from macro trendsJuly 2025 Momentum & Expert Curated Trade Setup Alerts - Newser
how to manage a losing position in nektar therapeuticsEarnings Performance Report & Risk Controlled Stock Pick Alerts - Newser
Nektar Therapeutics stock volume spike explained2025 Performance Recap & Community Verified Watchlist Alerts - Newser
How to interpret RSI for Nektar Therapeutics stock2025 Major Catalysts & Reliable Entry Point Trade Alerts - Newser
Can Nektar Therapeutics continue delivering strong returnsJuly 2025 News Drivers & Weekly Sector Rotation Insights - khodrobank.com
Can momentum traders help lift Nektar TherapeuticsBuy Signal & Community Verified Trade Alerts - Newser
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):